可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part 1[J]. J Lipid Res, 2004, 45(9):1583-1593.
[2] Brewer HB Jr. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease[J]. Arterioscler Thromb Vasc Biol, 2004, 24(3):387-391.
[3] 苏慧,黄晨,孙新,等. LPL基因HindⅢ多态性与高脂血症和冠心病的关系[J]. 心脏杂志, 2005, 17(6):599-602.
[4] 梁东辉,张暋,陈允钦,等. 老年糖尿病患者血脂调治的新思路附: 72例病例SPLG报告[J]. 成都中医药大学学报, 2004, 27(2):7-10.
[5] Birjmohun RS, Hutten BA, Kastelein JJ, et al. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a metaanalysis of randomized controlled trials[J]. J Am Coll Cardiol, 2005, 45(2):185-197.
[6] Clark RW, Sutfin TA, Ruggeri RB, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib[J]. Arterioscler Thromb Vasc Biol, 2004, 24(3):490-497.
[7] 汪俊元,王安才. 他汀类药物对血管重构的干预机制[J]. 心脏杂志, 2006, 18(3):356-358.
[8] 付文波,丁世芳. 他汀类药物对高血压病心血管重建作用的研究现状[J]. 心脏杂志, 2006, 18(5):588-590.
[9] 王松男,王玉东. 他汀类药物对冠心病强化降脂的研究进展[J]. 心脏杂志, 2007, 19(4):488-490.
[10]张青,贾春芳,李艳芳. 大剂量阿托伐他汀治疗冠心病并发高脂血症的有效性与安全性[J]. 心脏杂志, 2008, 20(2):187-189.
[11]成静,盛净,杜勤,等. 左卡尼汀对冠心病高胆固醇血症的疗效观察[J]. 心脏杂志, 2006, 18(4):430-431,435.
[12]Duffy D, Rader DJ. Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport[J]. Circulation, 2006, 113(8):1140-1150.